IMS MRL logo
University + MRL logo
CORD logo

Antonella Napolitano MD, PhD

Metabolic Director

CUC, GSK Addenbrookes Centre for

Clinical Investigation,Box128

Hills Road,Cambridge, CB2 2GG

Phone +44(0)1223 296075

Fax +44 (0) 1223 296108

Antonella.2.napolitano@gsk.com

 

Dr Napolitano is an endocrinologist and diabetologist with a special expertise in obesity and metabolic disorders and with research experience in both academia and industry for the past 20 years.  She joined GSK in 2003 as Clinical Investigation Physician and became Metabolic Platform Director in 2006.

 

Her main interest is implementing Experimental Medicine studies during early phases of drug development for compounds aimed at novel metabolic targets.  By translating data from animal models, she is also interested in identifying/validating human biomarkers of changes in energy balance in stratified patient populations and using them to predict the effectiveness of novel intervention in managing metabolic disorders with long-term outcomes.

 

Antonella Napolitano is an Honorary Consultant at the Department of Biochemistry, Cambridge University Hospitals, and Affiliated Member of The Royal College of Physicians/London; she obtained her MD and PhD at Padua University, Italy and did her post-doctoral training at Beth-Israel Hospital, Harvard Medical School and Western General Hospital, Edinburgh University